The Biden administration sends medical experts to the site of the derailed train carrying hazardous materials in Ohio; senators push for pharmacy benefit manager (PBM) reforms; Kentucky Supreme Court proceeds with near-total abortion ban.
Amid growing public safety concerns since a train carrying hazardous materials, including vinyl chloride, derailed in Ohio last week, the Biden administration has sent medical experts to assess any dangers to residents, according to CNN. An evacuation order that was sent in place has been lifted as of February 8. However, some residents are worried the testing is insufficient, as some individuals report smelling a chemical odor, headaches, and sore throats, and officials estimate thousands of fish killed by contamination were found downstream and in rivers.
During a heated hearing by the Senate Commerce Committee on Thursday, some Republican lawmakers accused pharmacy benefit managers (PBMs) of lacking transparency when directing patients toward pharmacies they own, according to Fierce Healthcare. In the hearing, pharmacies testified against contracts with PBMs, saying they have “zero negotiating power.” On the other hand, the Pharmaceutical Care Management Association, a PBM industry group, has pushed back on proposed legislation, blaming drug companies of “evergreening” and “patent thickets” that are blocking competitive drug prices.
On Thursday, Kentucky’s Supreme Court refused to overturn a near-total ban on abortion since the overturning of Roe v Wade, according to the Associated Press. Kentucky’s high court weighed in on issues concerning a statewide near-total abortion ban and an abortion ban after the sixth week of pregnancy. After voters rejected a ballot last year that would have denied any constitutional abortion protections, Republican legislation passed both laws.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More